Log In
Print this Print this


Also known as: AAV.REP1

  Manage Alerts
Collapse Summary General Information
Company NightstaRx Ltd.
DescriptionAdeno-associated viral (AAV) serotype 2 vector carrying the Rab escort protein 1 (CHM; REP1) gene
Molecular Target Rab escort protein 1 (CHM) (REP1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPhase II
Standard IndicationBlindness
Indication DetailsTreat choroideremia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today